Close Menu

Evotec

Erich Hunziker retires from Roche; Andrei Lyne becomes CFO at Synpromics; Werner Arber becomes president of the Pontifical Academy of Sciences; and More

The agreement calls for Kinaxo to provide quantitative analyses of PTMs on a proteome-wide scale with the expectation that "such comprehensive analysis will gain valuable insights into cellular functions of potential drug targets," the company said in a statement.

Kinaxo will use it mass spectrometry-based technologies to quantitatively analyze post-translational modifications in proteins on a proteome-wide scale.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Kinaxo will apply its technologies to deconvolute molecular targets of compounds on which the drug company is currently performing drug discovery work.

The firm will identify for Shionogi small molecule modulators of various protein-protein interaction targets.

The Japanese drug firm will use Kinaxo's Cellular Target Profiling, KinAffinity, and PhosphoScout products.

The acquisition adds drug discovery alliances to Evotec's portfolio of core assets, including one with Boehringer Ingelheim worth up to €237 million in potential milestone payments.

The deal adds to Evotec research funds and potential milestone payments associated with DeveloGen's discovery alliance with Boehringer Ingelheim on small molecules to treat type 2 diabetes.

Evotec will conduct high-throughput screening and chemical and biological studies for candidate compounds selected by Genentech.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.